Related Experiment Videos
Recombinant viral vector vaccines for the veterinary use
N Yokoyama1, K Maeda, T Mikami
1Department of Veterinary Microbiology, Faculty of Agriculture, University of Tokyo, Japan.
The Journal of Veterinary Medical Science
|May 1, 1997
Summary
Genetically engineered recombinant viral vaccines are being developed to overcome issues with current vaccines. This review focuses on herpesviruses, vaccinia viruses, and adenoviruses for veterinary applications.
Area of Science:
- Veterinary medicine
- Vaccinology
- Molecular biology
Background:
- Traditional viral vaccines face limitations.
- Recombinant DNA technology offers solutions for vaccine development.
- Genetically engineered vaccines aim to improve safety and efficacy.
Purpose of the Study:
- To review the application of recombinant DNA techniques in viral vaccine design.
- To highlight viruses extensively studied for veterinary recombinant vaccine development.
- To discuss herpesviruses, vaccinia viruses, and adenoviruses as vaccine platforms.
Main Methods:
- Review of scientific literature on recombinant viral vaccines.
- Analysis of studies focusing on veterinary applications.
- Identification of widely investigated viral vectors for vaccine delivery.
Main Results:
- Recombinant DNA technology enables the creation of novel viral vaccines.
- Herpesviruses, vaccinia viruses, and adenoviruses are prominent candidates for veterinary vaccines.
- These viruses serve as vectors for delivering foreign immunogenic antigens.
Conclusions:
- Recombinant viral vaccines hold significant promise for veterinary use.
- The selected viruses offer viable platforms for developing improved vaccines.
- Further research in this area can lead to enhanced animal health strategies.